EGFRvIII/GPC3-targeting CARs have been induced in pluripotent stem cell-derived macrophages that demonstrated improved antitumor effect through M1 polarization, tumor cell phagocytosis, and apoptotic tumor cell efferocytosis [68]. Here, GPC3 is linked to neoplasm.